Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial

被引：0
作者：
Mahshid Saleh
Amir Abbas Vaezi
Rasoul Aliannejad
Amir Ali Sohrabpour
Seyedeh Zahra Fotook Kiaei
Mahdi Shadnoush
Vahid Siavashi
Leila Aghaghazvini
Batoul Khoundabi
Shahriyar Abdoli
Bahram Chahardouli
Iman Seyhoun
Neda Alijani
Javad Verdi
机构：
[1] Tehran University of Medical Sciences,Department of Applied Cell Sciences, School of Advanced Technologies in Medicine
[2] Alborz University of Medical Sciences,Department of Internal Medicine
[3] Tehran University of Medical Sciences,Department of Pulmonary and Critical Care, Shariati Hospital
[4] Tehran University of Medical Sciences,Advanced Thoracic Research Center
[5] Tehran University of Medical Sciences,Associate Professor of Gastroenterology and Hepatology, Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute
[6] Tehran University of Medical Science,Advanced Thoracic Research Centre
[7] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition, Faculty of Nutrition & Food Technology
[8] University of Tehran,Department of Clinical Pathology, Faculty of Veterinary Medicine
[9] Tehran University of Medical Sciences,Associate Professor, Department of Radiology, Shariati Hospital
[10] Iran Helal Institute of Applied-Science and Technology,Pasteur Institute of Iran
[11] Research Center for Health Management in Mass Gathering,Hematology, Oncology, and Stem Cell Transplantation Research Center
[12] Red Crescent Society of the Islamic Republic of Iran,Department of Infectious Diseases, Shariati Hospital
[13] National Cell Bank of Iran,undefined
[14] Tehran University of Medical Sciences,undefined
[15] Tehran University of Medical Sciences,undefined
来源：
Stem Cell Research & Therapy | / 12卷
关键词：
COVID-19; WJ-MSC; Cell therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 413 条
[1]  
Munster VJ(2020)A novel coronavirus emerging in China — key questions for impact assessment New England Journal of Medicine. 382 692-694
[2]  
Koopmans M(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 497-506
[3]  
van Doremalen N(2020)Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study The Lancet Infectious Diseases. 20 425-434
[4]  
van Riel D(2020)Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Science China Life Sciences. 63 457-460
[5]  
de Wit E(2020)Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet (London, England) 395 565-574
[6]  
Huang C(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature. 579 270-273
[7]  
Wang Y(2004)Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis The Journal of pathology. 203 631-637
[8]  
Li X(2020)The pathogenesis and treatment of the ‘cytokine storm’ in COVID-19 Journal of infection. 80 607-613
[9]  
Ren L(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet (London, England) 395 497-506
[10]  
Zhao J(2020)Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion Radiology. 295 22-23
12345678910